Next Article in Journal
Chemokines as Cancer Vaccine Adjuvants
Next Article in Special Issue
Evaluation of Different DNA Vaccines against Porcine Reproductive and Respiratory Syndrome (PRRS) in Pigs
Previous Article in Journal / Special Issue
Clinical Development of a Cytomegalovirus DNA Vaccine: From Product Concept to Pivotal Phase 3 Trial
Vaccines 2013, 1(4), 415-443; doi:10.3390/vaccines1040415
Article

DNA-Encoded Flagellin Activates Toll-Like Receptor 5 (TLR5), Nod-like Receptor Family CARD Domain-Containing Protein 4 (NRLC4), and Acts as an Epidermal, Systemic, and Mucosal-Adjuvant

1, 2, 3, 3, 1,4, 5, 6, 7, 8, 3 and 1,*
Received: 18 July 2013; in revised form: 27 August 2013 / Accepted: 30 August 2013 / Published: 25 September 2013
(This article belongs to the Special Issue DNA Vaccines)
View Full-Text   |   Download PDF [940 KB, uploaded 25 September 2013]   |   Browse Figures
Abstract: Eliciting effective immune responses using non-living/replicating DNA vaccines is a significant challenge. We have previously shown that ballistic dermal plasmid DNA-encoded flagellin (FliC) promotes humoral as well as cellular immunity to co-delivered antigens. Here, we observe that a plasmid encoding secreted FliC (pFliC(-gly)) produces flagellin capable of activating two innate immune receptors known to detect flagellin; Toll-like Receptor 5 (TLR5) and Nod-like Receptor family CARD domain-containing protein 4 (NRLC4). To test the ability of pFliC(-gly) to act as an adjuvant we immunized mice with plasmid encoding secreted FliC (pFliC(-gly)) and plasmid encoding a model antigen (ovalbumin) by three different immunization routes representative of dermal, systemic, and mucosal tissues. By all three routes we observed increases in antigen-specific antibodies in serum as well as MHC Class I-dependent cellular immune responses when pFliC(-gly) adjuvant was added. Additionally, we were able to induce mucosal antibody responses and Class II-dependent cellular immune responses after mucosal vaccination with pFliC(-gly). Humoral immune responses elicited by heterologus prime-boost immunization with a plasmid encoding HIV-1 from gp160 followed by protein boosting could be enhanced by use of pFliC(-gly). We also observed enhancement of cross-clade reactive IgA as well as a broadening of B cell epitope reactivity. These observations indicate that plasmid-encoded secreted flagellin can activate multiple innate immune responses and function as an adjuvant to non-living/replicating DNA immunizations. Moreover, the capacity to elicit mucosal immune responses, in addition to dermal and systemic properties, demonstrates the potential of flagellin to be used with vaccines designed to be delivered by various routes.
Keywords: adaptive immunity; DNA adjuvant; flagellin; NLRC4; TLR5 adaptive immunity; DNA adjuvant; flagellin; NLRC4; TLR5
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Nyström, S.; Bråve, A.; Falkeborn, T.; Devito, C.; Rissiek, B.; Johansson, D.X.; Schröder, U.; Uematsu, S.; Akira, S.; Hinkula, J.; Applequist, S.E. DNA-Encoded Flagellin Activates Toll-Like Receptor 5 (TLR5), Nod-like Receptor Family CARD Domain-Containing Protein 4 (NRLC4), and Acts as an Epidermal, Systemic, and Mucosal-Adjuvant. Vaccines 2013, 1, 415-443.

AMA Style

Nyström S, Bråve A, Falkeborn T, Devito C, Rissiek B, Johansson DX, Schröder U, Uematsu S, Akira S, Hinkula J, Applequist SE. DNA-Encoded Flagellin Activates Toll-Like Receptor 5 (TLR5), Nod-like Receptor Family CARD Domain-Containing Protein 4 (NRLC4), and Acts as an Epidermal, Systemic, and Mucosal-Adjuvant. Vaccines. 2013; 1(4):415-443.

Chicago/Turabian Style

Nyström, Sanna; Bråve, Andreas; Falkeborn, Tina; Devito, Claudia; Rissiek, Björn; Johansson, Daniel X.; Schröder, Ulf; Uematsu, Satoshi; Akira, Shizuo; Hinkula, Jorma; Applequist, Steven E. 2013. "DNA-Encoded Flagellin Activates Toll-Like Receptor 5 (TLR5), Nod-like Receptor Family CARD Domain-Containing Protein 4 (NRLC4), and Acts as an Epidermal, Systemic, and Mucosal-Adjuvant." Vaccines 1, no. 4: 415-443.


Vaccines EISSN 2076-393X Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert